Oncode Scientific Sdn Bhd
201501029484 (1154805-X)
Leading the Precision Medicine Revolution in Asia
Since 2015, Oncode Scientific Sdn Bhd has emerged as a trailblazer in the realm of precision medicine, setting new benchmarks in cancer molecular diagnostics. Our multidisciplinary team, comprising top-tier experts from molecular science and clinical practice, brings together decades of experience in medical diagnostics and research. At our cutting-edge facilities in Malaysia, we spearhead one of Asiaโs most pioneering precision medicine initiatives, specializing in both solid tumors and hematologic cancers. Our relentless pursuit of innovation drives us to constantly challenge the status quo, exceeding clinical and diagnostic standards to deliver groundbreaking medical solutions. Oncode is dedicated to transforming healthcareโadvancing disease prevention, early detection, and targeted intervention. With a commitment to excellence, we provide world-class molecular diagnostic services that are both accessible and revolutionary, empowering the global community to embrace the full potential of precision medicine.
14/11/2025
We will be at ๐๐ฒ๐ป๐ฒ๐๐ถ๐ฐ ๐๐ผ๐๐ป๐๐ฒ๐น๐น๐ผ๐ฟ ๐๐๐ฎ๐ฟ๐ฒ๐ป๐ฒ๐๐ ๐๐ฎ๐ ๐ฎ๐ฌ๐ฎ๐ฑ (๐๐๐๐ ๐ฎ๐ฌ๐ฎ๐ฑ)! Drop by the Oncode booth to explore reliable genomic solutions for confident, informed clinical decisions.
Check out our morning tea break talk on ๐๐ผ๐ ๐ช๐ต๐ผ๐น๐ฒ ๐๐ ๐ผ๐บ๐ฒ ๐ฆ๐ฒ๐พ๐๐ฒ๐ป๐ฐ๐ถ๐ป๐ด ๐ฅ๐ฒ๐ณ๐ถ๐ป๐ฒ๐ ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ถ๐ฎ๐ด๐ป๐ผ๐๐ถ๐, delivered by Dr. Muzhirah Aisha Haniffa.
๐ Date: 15 November 2025
โฐ Time: 8:00AM โ 5:00PM
๐ Location: Pearl & Amethyst Hall, Perdana Hotel Kuala Lumpur
10/11/2025
As part of a collaborative continuing medical education (CME) session with Astellas, Oncode had the opportunity to engage with the enthusiastic ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ฎ๐ฒ๐บ๐ฎ๐๐ผ๐น๐ผ๐ด๐ ๐๐ฒ๐ฎ๐บ ๐ฎ๐ ๐๐ผ๐๐ฝ๐ถ๐๐ฎ๐น ๐ฆ๐๐น๐๐ฎ๐ป ๐๐ฏ๐ฑ๐๐น ๐๐๐ถ๐ ๐ฆ๐ต๐ฎ๐ต, ๐จ๐ป๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐ถ ๐ฃ๐๐๐ฟ๐ฎ ๐ ๐ฎ๐น๐ฎ๐๐๐ถ๐ฎ (๐๐ฆ๐๐๐ฆ ๐จ๐ฃ๐ ) on 4th August 2025.
The session covered key insights into ๐๐๐ง๐ฏ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป๐ (๐๐๐ง๐ฏ๐บ), the most common genetic alterations in ๐๐ฐ๐๐๐ฒ ๐ ๐๐ฒ๐น๐ผ๐ถ๐ฑ ๐๐ฒ๐๐ธ๐ฒ๐บ๐ถ๐ฎ (๐๐ ๐), and compared available testing methods, outlining their clinical applications and limitations. We underscored the need for ๐ฟ๐ฎ๐ฝ๐ถ๐ฑ ๐๐๐ฟ๐ป๐ฎ๐ฟ๐ผ๐๐ป๐ฑ ๐๐ถ๐บ๐ฒ in guiding timely, effective treatment, and showcased ๐ฐ๐ฎ๐๐ฒ ๐๐๐๐ฑ๐ถ๐ฒ๐ highlighting the role of ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐บ๐ผ๐ป๐ถ๐๐ผ๐ฟ๐ถ๐ป๐ด in AML management.
The session also spotlighted the ๐๐๐ง๐ฏ๐บ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐๐ผ๐ฝ๐ฎ๐ ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ ๐ฏ๐ ๐ข๐ป๐ฐ๐ผ๐ฑ๐ฒ & ๐๐๐๐ฒ๐น๐น๐ฎ๐, providing ๐๐๐ฏ๐๐ถ๐ฑ๐ถ๐๐ฒ๐ฑ ๐๐ฒ๐๐๐ถ๐ป๐ด for HSAAS UPM patients with relapsed or refractory AML.
Grateful for the meaningful discussions and shared commitment to advancing precision haematology.
We are honoured to be part of ๐ก๐๐ถ๐ผ๐ฆ๐๐ข๐ช๐๐๐ฆ๐ ๐ฎ๐ฌ๐ฎ๐ฑ, held in conjunction with ๐๐๐๐๐ฆ๐ฎ๐ฑ in Sarawak โ where innovators, researchers, and changemakers came together to reimagine the future of bioeconomy and technology.
We are also delighted to have our ๐๐ผ๐๐ป๐ฑ๐ถ๐ป๐ด ๐๐๐ข, ๐๐๐๐ผ๐ฐ. ๐ฃ๐ฟ๐ผ๐ณ. ๐๐ฟ. ๐ฆ๐ ๐ช๐ฒ๐ป ๐๐ถ๐บ, invited as a speaker at ๐๐๐๐๐ฆ๐ฎ๐ฑ, where she delivered an inspiring reflection titled โHealing the Future City: Building Health Systems That Think, Adapt & Care.โ
In her keynote, Dr. Lim reminded audiences that as nations race to build smarter and more connected cities, true progress cannot be measured by speed, scale, or technology alone โ but by the health and well-being of the people who live within them.
She urged a redefinition of progress: from technology as a competition of advancement, to technology as an act of healing โ one that restores balance between people, planet, and progress. Because the future city is not just smart โ it must also be compassionate.
At Oncode, this belief forms the foundation of everything we do.
We are building technologies that heal, restore, and uplift humanity โ systems that think intelligently, adapt naturally, and care deeply.
๐ก โTechnology is not about invention for its own sake, nor competition for prestige โ its very reason to exist is to heal, restore, and uplift lives.โ โ ๐๐๐๐ผ๐ฐ. ๐ฃ๐ฟ๐ผ๐ณ. ๐๐ฟ. ๐ฆ๐ ๐ช๐ฒ๐ป ๐๐ถ๐บ
We extend our heartfelt thanks to Bioeconomy Corporation for the kind invitation and for hosting us. We deeply value the opportunity to share our vision among fellow innovators and changemakers who are shaping a future where science and technology work hand in hand to improve lives.
19/10/2025
โจ Wishing everyone a bright and joyful Deepavali!
May this Festival of Lights remind us that even the smallest glow can illuminate the world. ๐
15/10/2025
Weโre honoured that our Founding CEO, Assoc. Prof. Dr. Su Wen Lim, was invited as one of the distinguished panelists at BioXCeed 2025, held in conjunction with The National Innovation and Commercialisation Expo (NICE 2025) by Kementerian Sains, Teknologi dan Inovasi (MOSTI).
Under the BioXCeed 2025 segment โ jointly driven by MTDC and Bioeconomy Corporation, the event showcases cutting-edge deep-tech and bioeconomy solutions, bringing together innovators, investors, and industry leaders driving Malaysiaโs bioeconomy forward.
Dr. Lim joined the panel discussion on โ๐๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ถ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ฆ๐๐ฐ๐ฐ๐ฒ๐๐: ๐๐ฒ๐๐ผ๐ป๐ฑ ๐ ๐ฎ๐น๐ฎ๐๐๐ถ๐ฎโ๐ ๐๐ผ๐ฟ๐ฑ๐ฒ๐ฟ๐โ, moderated by En. Norazil Mohamad Nor (Xeraya Capital), alongside esteemed speakers Dr. Faizal Hamid (Bioeconomy Corporation), Ts. Dr. Indera Shaiful Baharudin, PhD (Malaysian Technology Development Corporation (MTDC)), and Noor Shazreena Ishak (Bio-Angle Vacs Sdn. Bhd.).
Dr. Lim shared Oncodeโs journey from a small Malaysian molecular diagnostics lab into a regional precision medicine group โ highlighting how innovation, credibility, and ecosystem support empower local MSMEs to scale beyond borders.
A heartfelt thanks to Bioeconomy Corporation for the kind invitation, and to MOSTI, Bioeconomy Corporation and Malaysian Technology Development Corporation (MTDC), for hosting this impactful platform championing Malaysiaโs innovation and bioeconomy landscape. ๐
14/10/2025
On 1st October 2025, Oncode conducted a CME session at the ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐ฎ๐ป๐ฑ ๐ฅ๐ฎ๐ฑ๐ถ๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ ๐๐ฒ๐ฝ๐ฎ๐ฟ๐๐บ๐ฒ๐ป๐, ๐๐ผ๐๐ฝ๐ถ๐๐ฎ๐น ๐๐ฎ๐ป๐๐ฒ๐น๐ผ๐ฟ ๐ง๐๐ฎ๐ป๐ธ๐ ๐ ๐๐ต๐ฟ๐ถ๐ (๐๐๐ง๐ ๐จ๐๐ ) on the topic โ๐๐ ๐ฝ๐น๐ผ๐ฟ๐ถ๐ป๐ด ๐๐ต๐ฒ ๐ฅ๐ผ๐น๐ฒ ๐ผ๐ณ ๐ก๐๐ฆ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐ถ๐ป ๐ฃ๐ฒ๐ฟ๐๐ผ๐ป๐ฎ๐น๐ถ๐๐ฒ๐ฑ ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐ฎ๐ฟ๐ฒ.โ
The session provided an in-depth comparison between ๐ฃ๐๐ฅ ๐ฎ๐ป๐ฑ ๐ก๐๐ฆ ๐๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ถ๐ฒ๐ in lung cancer profiling, highlighting their impact on ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ ๐ฎ๐ฐ๐ฐ๐๐ฟ๐ฎ๐ฐ๐ ๐ฎ๐ป๐ฑ ๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐ฑ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป๐. It also addressed the ๐ฏ๐ถ๐ผ๐ถ๐ป๐ณ๐ผ๐ฟ๐บ๐ฎ๐๐ถ๐ฐ๐, ๐ฑ๐ฎ๐๐ฎ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐, ๐ฎ๐ป๐ฑ ๐ฟ๐ถ๐ด๐ผ๐ฟ๐ผ๐๐ ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ฐ๐ผ๐ป๐๐ฟ๐ผ๐น in ensuring precision within molecular laboratories.
Participants were also introduced to Oncodeโs ๐๐๐ฏ๐๐ถ๐ฑ๐ถ๐๐ฒ๐ฑ ๐น๐๐ป๐ด ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ, ๐๐ฅ๐ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐ผ๐๐ฎ๐ฟ๐ถ๐ฎ๐ป ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ, ๐ฎ๐ป๐ฑ ๐น๐ถ๐พ๐๐ถ๐ฑ/๐๐ถ๐๐๐๐ฒ ๐ฏ๐ถ๐ผ๐ฝ๐๐ ๐ฎ๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ across multiple cancer types.
Thank you to the HCTM team for your engagement and commitment to advancing personalised oncology care.
14/10/2025
On 29th August 2025, Oncode was honoured to participate in ๐๐ฒ๐ฎ๐ฐ๐ผ๐ป ๐๐ผ๐๐ฝ๐ถ๐๐ฎ๐นโ๐ ๐ฆ๐ฒ๐ป๐ถ๐ผ๐ฟ ๐ฆ๐๐ฎ๐ณ๐ณ ๐ก๐๐ฟ๐๐ฒ ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐๐ป๐ฑ๐๐ฐ๐๐ถ๐ผ๐ป ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ๐บ๐ฒ, delivering an engaging CME session on ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ถ๐ป๐ฒ ๐ถ๐ป ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ.
The session explored the shift from ๐ผ๐ป๐ฒ-๐๐ถ๐๐ฒ-๐ณ๐ถ๐๐-๐ฎ๐น๐น ๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ to ๐ฝ๐ฒ๐ฟ๐๐ผ๐ป๐ฎ๐น๐ถ๐๐ฒ๐ฑ ๐ฐ๐ฎ๐ฟ๐ฒ ๐ด๐๐ถ๐ฑ๐ฒ๐ฑ ๐ฏ๐ ๐ฒ๐ฎ๐ฐ๐ต ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐โ๐ ๐ด๐ฒ๐ป๐ฒ๐๐ถ๐ฐ ๐ฝ๐ฟ๐ผ๐ณ๐ถ๐น๐ฒ. We highlighted the value of ๐ก๐๐ฆ ๐๐ฒ๐๐๐ถ๐ป๐ด, real-world ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐ฝ๐ฟ๐ผ๐ณ๐ถ๐น๐ถ๐ป๐ด ๐ฐ๐ฎ๐๐ฒ ๐๐๐๐ฑ๐ถ๐ฒ๐, and the emerging role of ๐น๐ถ๐พ๐๐ถ๐ฑ ๐ฏ๐ถ๐ผ๐ฝ๐๐ถ๐ฒ๐ in making cancer diagnostics more accessible.
Importantly, we emphasised the ๐ฐ๐ฟ๐ถ๐๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ผ๐น๐ฒ ๐ผ๐ณ ๐ผ๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐ป๐๐ฟ๐๐ฒ๐ in educating patients, managing side effects, and ensuring coordinated care throughout the treatment journey.
The session concluded with an interactive quiz, reinforcing key takeaways in a fun and memorable way.
Thank you for having us, Beacon Hospital โ hereโs to empowering oncology care through knowledge and precision.
05/10/2025
At Oncode, we believe health and harmony shine brightest when shared.๐
May this festive season bring you joy, wellness, and togetherness under the full moon.
27/09/2025
Oncode is at the ๐ฏ๐ฒ๐๐ต ๐๐ป๐ป๐๐ฎ๐น ๐ฆ๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ ๐ฎ๐น๐ฎ๐๐๐ถ๐ฎ๐ป ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น ๐ฆ๐ผ๐ฐ๐ถ๐ฒ๐๐ (๐๐ฆ๐๐ข๐ ๐ข๐ฆ ๐ฎ๐ฌ๐ฎ๐ฑ) this weekend, championing innovation and quality in precision oncology.
๐ 26โ28 September 2025
๐ Persada Johor International Convention Centre, Malaysia
1๏ธโฃ Actionable Mutation Landscape in Malaysiaโs Top Three Cancers: Insights from Routine NGS Testing with EQA-Assured Accuracy
๐ Selected as a ๐ง๐ผ๐ฝ ๐ญ๐ฌ ๐ฃ๐ผ๐๐๐ฒ๐ฟ ๐๐ถ๐ป๐ฎ๐น๐ถ๐๐. Join us for the live poster presentation, taking place at the Foyer.
๐ 27 Sept | ๐ 3:15โ4:15PM | ๐ Foyer outside Tanjung Puteri Convention Halls (Level 3)
2๏ธโฃ Bridging Gaps in Cancer Diagnostics: Implementation of a 500-Gene Comprehensive Genomic Profiling Panel to Support Precision Oncology in Malaysia
-
๐ค ๐ฉ๐ถ๐๐ถ๐ ๐จ๐ ๐ฎ๐ ๐๐ผ๐ผ๐๐ต ๐๐ฎ๐ฌ
Discover how weโre redefining solid tumour diagnostics and care with advanced tissue- and liquid-based molecular solutions.
โจ Together, letโs turn genomic insights into hope โ advancing oncology with trusted molecular diagnostics.
22/09/2025
On 27th August 2025, Oncode conducted a CME session with the ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ฎ๐ฒ๐บ๐ฎ๐๐ผ๐น๐ผ๐ด๐ ๐๐ฒ๐ฎ๐บ ๐ฎ๐ ๐จ๐ป๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐ ๐ ๐ฎ๐น๐ฎ๐๐ฎ ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ป๐๐ฟ๐ฒ (๐จ๐ ๐ ๐) on โ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐๐ฝ๐ฝ๐ฟ๐ผ๐ฎ๐ฐ๐ต๐ฒ๐ ๐ถ๐ป ๐๐๐ง๐ฏ-๐ ๐๐๐ฎ๐๐ฒ๐ฑ ๐ฎ๐ป๐ฑ ๐ฅ๐ฒ๐น๐ฎ๐ฝ๐๐ฒ๐ฑ/๐ฅ๐ฒ๐ณ๐ฟ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ ๐.โ
The session compared ๐๐๐ง๐ฏ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ฒ๐๐๐ถ๐ป๐ด ๐๐ฒ๐ฐ๐ต๐ป๐ถ๐พ๐๐ฒ๐, highlighting their ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ฒ๐น๐ฒ๐๐ฎ๐ป๐ฐ๐ฒ, ๐น๐ถ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป๐, and the critical need for ๐ณ๐ฎ๐๐ ๐๐๐ฟ๐ป๐ฎ๐ฟ๐ผ๐๐ป๐ฑ ๐๐ถ๐บ๐ฒ in guiding treatment. ๐๐ฎ๐๐ฒ ๐๐๐๐ฑ๐ถ๐ฒ๐ demonstrated the value of ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐บ๐ผ๐ป๐ถ๐๐ผ๐ฟ๐ถ๐ป๐ด in AML management.
We also introduced the ๐ข๐ป๐ฐ๐ผ๐ฑ๐ฒโ๐๐๐๐ฒ๐น๐น๐ฎ๐ ๐๐๐ง๐ฏ๐บ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐๐ผ๐ฝ๐ฎ๐ ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ๐บ๐ฒ, offering ๐๐๐ฏ๐๐ถ๐ฑ๐ถ๐๐ฒ๐ฑ ๐๐๐ง๐ฏ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ฒ๐๐๐ถ๐ป๐ด for eligible UMMC patients.
Thank you to the UMMC team for your active participation in advancing precision haematology.
17/09/2025
On 6th August 2025, Oncode conducted a focused CME session at ๐๐ผ๐๐ฝ๐ถ๐๐ฎ๐น ๐ฆ๐๐น๐๐ฎ๐ป๐ฎ๐ต ๐๐ฎ๐ต๐ถ๐๐ฎ๐ต, bringing together a group of dedicated clinical haematology staff.
The session focused on ๐ฝ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐ฎ๐ฝ๐ฝ๐ฟ๐ผ๐ฎ๐ฐ๐ต๐ฒ๐ ๐ถ๐ป ๐๐๐ง๐ฏ-๐บ๐๐๐ฎ๐๐ฒ๐ฑ ๐ฎ๐ป๐ฑ ๐ฟ๐ฒ๐น๐ฎ๐ฝ๐๐ฒ๐ฑ/๐ฟ๐ฒ๐ณ๐ฟ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ฐ๐๐๐ฒ ๐ ๐๐ฒ๐น๐ผ๐ถ๐ฑ ๐๐ฒ๐๐ธ๐ฒ๐บ๐ถ๐ฎ (๐๐ ๐), given the intermediate risk posed by FLT3-ITD mutations and the available targeted FLT3 inhibitor treatment options. We also emphasised the critical importance of ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ฎ๐ ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐น ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐ถ๐ ๐ฎ๐ป๐ฑ ๐ฟ๐ฒ๐น๐ฎ๐ฝ๐๐ฒ๐ฑ/๐ฟ๐ฒ๐ณ๐ฟ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐ฑ๐ถ๐๐ฒ๐ฎ๐๐ฒ to determine mutation status and support timely, informed treatment decisions.
Thank you to the Hospital Sultanah Bahiyah team for your continued commitment to advancing precision medicine in haematology.
15/09/2025
โจ Happy Malaysia Day! โจ
Today we celebrate not only the unity of our nation, but also the shared journey towards a stronger, healthier future.
Oncode Scientific is proud to stand with Malaysia โ advancing science, empowering healthcare, and shaping hope for generations to come. ๐
Address
Lot 03-01, 3rd Floor. Hap Seng Business Park, No. 12, Persiaran Perusahaan, Unity Square. Seksyen 23, Shah Alam D. E. Shah Alam 40300
Be the first to know and let us send you an email when Oncode Scientific Sdn Bhd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
ONCODE Scientific Sdn Bhd was founded in 2015, by a strong knowledge-based management and operational team with the combination of more than 85 years of experience in the areas of medical diagnostics and scientific research. Itโs aims to be a niche player specializing in Precision Medicine utilizing the techniques of Next Generation Sequencing (NGS), Sanger sequencing, Real-Time & Standard PCR technologies. The team comprises of scientists, geneticists, physicians, pharmacists, bioinformaticians and business veterans who aim to deliver the best quality and affordable molecular diagnostic solutions to the global community.
Oncode laboratory workflows and pipelines include internal and external validation quality controls for compliance with international standards of Good Laboratory Practice (GLP), ISO 15189, the Association for Molecular Pathology (AMP) and the College of American Pathologist (CAP).
The laboratory participates in external quality assurance and proficiency programs including the UK National External Quality Assurance System (UKNEQAS), The European Molecular Genetics Quality Network (EMQN) and the Royal College of Pathologists of Australasia (RCPA).
Oncode Mission
To provide quality diagnostic solutions to customers through the implementation of state-of-the-art laboratory setup designed to worldwide standards, recruitment of dedicated professionals and comprehensive reporting systems.
Oncode Objective
To be a regional one-stop molecular genetics solution center, delivering powerful diagnostic support and insight to medical professionals
